A well-controlled clinical study by Thorburn et al (1998) showed that serum hyper-gastrinaemia was associated with a 3.3-fold increase in the relative risk of developing colorectal cancer with 8.9% of colorectal cancers attributable to increased serum gastrin levels. Here, GAST is linked to colorectal cancer.